Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Re-Pricing Rule for Indication Expansions Mars I/O Development: MSD Japan Chief
March 14, 2018
- Gilead Japan Rolling Up Its Sleeves for Foray into Oncology/Inflammation Market
March 14, 2018
- Toyama Chemical Begins Patient Enrollment in Japan PIII Study of Avigan for SFTS
March 13, 2018
- EA Pharma’s Livact Now Available in Thailand
March 12, 2018
- Solifenacin Oral Suspension Approved in Europe for Pediatric NDO: Astellas
March 12, 2018
- Costa Saroukos Tapped as Takeda’s Global CFO
March 9, 2018
- Hiroo Ito Named New President of Actelion Pharmaceuticals Japan
March 9, 2018
- Daiichi Sankyo’s ADC DS-8201 Enters Global PII Study for Colorectal Cancer
March 9, 2018
- Aducanumab Trial Tweak Has No Impact on Probability of Success: Eisai CEO
March 9, 2018
- Eisai Bags Up-to-US$5.76 Billion Lenvima Alliance with Merck
March 9, 2018
- Foreign Drug Makers Increased Market Share to Over 60% among Top 20 Makers in 2017
March 9, 2018
- Torii’s Futhan to Get 43.4% Price Cut in April, Urinorm 24.6%: Top 5 Product Survey
March 8, 2018
- Insomnia Drug Lemborexant Hits PIII Goals in Sleep Disorders: Eisai
March 8, 2018
- US FDA Approves Latuda for Pediatric Use in Bipolar I Depression: Sumitomo Dainippon
March 8, 2018
- Yoshikazu Aoki Named as New Asahi Kasei Pharma President
March 8, 2018
- Mid-Sized Japan Makers to Take Heaviest Hit from April Price Cut, Bigger Peers See Smaller Reductions: Jiho Survey
March 7, 2018
- Average NHI Price Reduction Rate of 12.8% for 3 Major Generic Makers: Jiho Tally
March 7, 2018
- Astellas, Tottori Univ. Pair Up to Develop, Commercialize Immunostimulating Gene Loading Oncolytic Virus
March 7, 2018
- Takeda Consumer Healthcare President Sugimoto to Step Down following 1 Year Stint since Firm’s Inception
March 7, 2018
- Alcon Pharma Reorganizes Marketing System to Boost Market Shares of Major Products including Lucentis
March 5, 2018
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…